Inhibition of experiment murine tumors by MT81, a new mycotoxin from Penicillium nigricans

Neoplasma

Volumn 44, Issue 5, 1997, Pages 329-333

  Gupta, M ^a   Majumdar, U K ^a   Ray, M R ^b   Mukhopadhayay, D K ^a  

^a JADAVPUR UNIVERSITY   (India)

^b CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Mice; MT81; New mycotoxin; Tumor inhibition

Indexed keywords

MT 81; MYCOTOXIN; UNCLASSIFIED DRUG; ANTHRAQUINONE DERIVATIVE; MT81 MYCOTOXIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; DRUG CONFORMATION; DRUG EFFECT; DRUG ISOLATION; EHRLICH ASCITES TUMOR; HUMAN; MALE; MITOSIS INDEX; MOUSE; PENICILLIUM; SARCOMA; STRUCTURE ACTIVITY RELATION; ANIMAL; BODY WEIGHT; CANCER TRANSPLANTATION; CHEMISTRY; EXPERIMENTAL NEOPLASM; INTRAPERITONEAL DRUG ADMINISTRATION; MORTALITY;

ANIMALS; ANTHRAQUINONES; BODY WEIGHT; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MYCOTOXINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL;

EID: 0031283115     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. AGUILAR, F., HUSSAIN, S.P., CERUTTI, P.: Aflatoxin B1 induces the transversion of G - T in codon of p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad.Sci. USA, 90, 1993, 8586-8590.
2. ANWAR, W.A., WILD, C.P.: Report on inaugural meeting Mycotoxins as mutagens and carcinogens. Possibilities for disease prevention. Mutat. Res., 312, 1994, 61-63.
3. CHOUDHURY, S., RANA, M.P., CHATTERJEE, T.K., MAJUMDAR, U.K., GUPTA, M.: Antimicrobial activities of mycotoxin MT81 and its structural derivatives, I. J. Exp. Biol., 30, 1992, 140-141.
4. DOLL, D.C., WEISS, R.B.: Chemotherapeutic agents and erythron. Cancer Treat. Rev., 10, 1993, 185-200.
5. FIMIANI, V.,RICHETTI, A.: Antitumor effect of a mycotoxin: Rubratoxin B. Chemotherapy, 39, 1993, 59-62.
6. HOGLAND, H.C.: Hematological complications of cancer chemotherapy. Semin. Oncol., 9, 1982, 95-102.
7. PRICE, V.E., GREENFIELD, R.E.: Anemia in cancer. In: Advance in Cancer Research, Vol. 5. Eds: Grenstein, J.P, Haddow, A. New York, Academic Press 1958, 199-290.
8. SATO, N., IETOY, Y., SAITO, M., ENOMOTO, M., TSUNODA, H.: Hydroxyanthraquinone. In: The Chemistry and Biology of Antibiotics, Vol. 8. Ed.: Betina, V. Amsterdam, Elsevier 1983, 329-350.
9. UENO, Y.: Biological effects of mycotoxin. In: The Chemistry and Biology of Antibiotics, Vol. 8. Ed.: Betina, V. Amsterdam, Elsevier 1983, 25-36.
10. WEI, X., SULIK, K.K.: Pathogenesis of craniofacial and body wall malformations induced by Ochratoxin A in mice. Am. J. Med. Genet., 47, 1993, 862-871.
11. WICK, M.M.: Dopamine: Novel antitumor agent against B-16 melanoma in vivo. J. Invest. Dermatol., 71, 1978, 163-164.
12. WINTROBE, M.M., LEE, G.R., BOGGS, D.R., BITHELL, T.C., ATHENS, J.W., FOESTER, J.: Clinical Hematology. Philadelphia, Lea and Febiger 1974.